Nicholas J. Brady

1.6k total citations
28 papers, 1.0k citations indexed

About

Nicholas J. Brady is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Nicholas J. Brady has authored 28 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Nicholas J. Brady's work include Cancer Cells and Metastasis (7 papers), Bone Metabolism and Diseases (6 papers) and Prostate Cancer Treatment and Research (5 papers). Nicholas J. Brady is often cited by papers focused on Cancer Cells and Metastasis (7 papers), Bone Metabolism and Diseases (6 papers) and Prostate Cancer Treatment and Research (5 papers). Nicholas J. Brady collaborates with scholars based in United States, China and Israel. Nicholas J. Brady's co-authors include Kathryn L. Schwertfeger, Pavlina Chuntova, Laurie H. Glimcher, Weiguo Zou, Dallas C. Jones, Matthew B. Greenblatt, Jae‐Hyuck Shim, Dorothy Hu, Todd P. Knutson and Sutada Lotinun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Nicholas J. Brady

28 papers receiving 1.0k citations

Peers

Countries citing papers authored by Nicholas J. Brady

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Brady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Brady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Brady more than expected).

Fields of papers citing papers by Nicholas J. Brady

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Brady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Brady. The network helps show where Nicholas J. Brady may publish in the future.

Co-authorship network of co-authors of Nicholas J. Brady

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Brady. A scholar is included among the top collaborators of Nicholas J. Brady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Brady. Nicholas J. Brady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ASCL1 Drives the Development of Neuroendocrine Prostate Cancer 2024 ·Cancer Research ·(unknown), Nicholas J. Brady	2
2	The Impact of Metabolic Syndrome and Obesity on Perioperative Total Joint Arthroplasty Outcomes: The Obesity Paradox and Risk Assessment in Total Joint Arthroplasty 2023 ·Arthroplasty Today ·(unknown), (unknown), (unknown), (unknown), Nicholas J. Brady, (unknown)	9
3	Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer 2021 ·Nature Communications ·Nicholas J. Brady, (unknown), Richa Singh, Vincenza Conteduca, Lucie Van Emmenis, (unknown), Hubert Pakula, (unknown), Francesca Khani, Martin Bakht, Michael Sigouros, Rohan Bareja, Andrea Sboner, Olivier Elemento, Scott T. Tagawa, David M. Nanus, Massimo Loda, Himisha Beltran, Brian D. Robinson, David S. Rickman	50
4	RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer 2021 ·Cancer Research ·Mark P. Labrecque, Lisha G. Brown, Ilsa M. Coleman, Bryce Lakely, Nicholas J. Brady, John K. Lee, Holly M. Nguyen, Dapei Li, Brian Hanratty, Michael C. Haffner, David S. Rickman, Lawrence D. True, Daniel W. Lin, Hung‐Ming Lam, Joshi J. Alumkal, Eva Corey, Peter S. Nelson, Colm Morrissey	23
5	STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment 2021 ·Breast Cancer Research ·(unknown), Nicholas J. Brady, (unknown), (unknown), Christine H. O’Connor, Kathryn L. Schwertfeger	24
6	N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer 2019 ·Journal of Clinical Investigation ·Adeline Berger, Nicholas J. Brady, Rohan Bareja, Brian Robinson, Vincenza Conteduca, Michael A. Augello, Loredana Puca, Adnan Ahmed, Étienne Dardenne, Xiaodong Lü, Inah Hwang, (unknown), Andrea Sboner, Olivier Elemento, Jihye Paik, Jindan Yu, Christopher E. Barbieri, Noah Dephoure, Himisha Beltran, David S. Rickman	116
7	JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2019 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Nicholas J. Brady, Pavlina Chuntova, Ying Wang, Todd P. Knutson, Christine Henzler, (unknown), Rachel I. Vogel, Andrew C. Nelson, Michael A. Farrar, Kathryn L. Schwertfeger	68
8	Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes 2018 ·Molecular Cancer Research ·Thu H. Truong, (unknown), Nuri A. Temiz, (unknown), Brian J. Girard, Nicholas J. Brady, Kathryn L. Schwertfeger, Carol A. Lange, Julie H. Ostrander	20
9	STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development 2017 ·Developmental Biology ·Nicholas J. Brady, Michael A. Farrar, Kathryn L. Schwertfeger	22
10	Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions 2017 ·PLoS ONE ·(unknown), Cynthia L. Forsman, Nicholas J. Brady, (unknown), (unknown), Deepali Sachdev, Eric D. Jensen, Kim C. Mansky, Kathryn L. Schwertfeger	25
11	SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts 2017 ·Nature Communications ·Zhan Xu, Matthew B. Greenblatt, Guang Yan, (unknown), Jun Sun, Sutada Lotinun, Nicholas J. Brady, Roland Baron, Laurie H. Glimcher, Weiguo Zou	60
12	Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs 2017 ·Journal of Hematology & Oncology ·Todd P. Knutson, Thu H. Truong, Shihong Ma, Nicholas J. Brady, Megan Sullivan, Ganesh V. Raj, Kathryn L. Schwertfeger, Carol A. Lange	65
13	Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer 2016 ·Mediators of Inflammation ·Nicholas J. Brady, Pavlina Chuntova, Kathryn L. Schwertfeger	72
14	Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival 2015 ·Molecular Cancer ·Mariya Farooqui, Laura R. Bohrer, Nicholas J. Brady, Pavlina Chuntova, Sarah E. Kemp, (unknown), Andrew C. Nelson, Kathryn L. Schwertfeger	28
15	Activation of the FGFR–STAT3 Pathway in Breast Cancer Cells Induces a Hyaluronan-Rich Microenvironment That Licenses Tumor Formation 2013 ·Cancer Research ·Laura R. Bohrer, Pavlina Chuntova, (unknown), Thomas C. Beadnell, Ronald P. Leon, Nicholas J. Brady, (unknown), Jodi E. Goldberg, Stephen C. Schmechel, Joseph S. Koopmeiners, James B. McCarthy, Kathryn L. Schwertfeger	59
16	The FGF/FGF receptor axis as a therapeutic target in breast cancer 2013 ·Expert Review of Endocrinology & Metabolism ·Nicholas J. Brady, Pavlina Chuntova, (unknown), Kathryn L. Schwertfeger	40
17	Schnurri-3 regulates ERK downstream of WNT signaling in osteoblasts 2013 ·Journal of Clinical Investigation ·Jae‐Hyuck Shim, Matthew B. Greenblatt, Weiguo Zou, Zhiwei Huang, Marc N. Wein, Nicholas J. Brady, Dorothy Hu, Jean Charron, (unknown), Gregory A. Petsko, Dennis M. Zaller, Bo Zhai, Steven P. Gygi, Laurie H. Glimcher, Dallas C. Jones	52
18	The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption 2012 ·Bone ·Julia F. Charles, Fabienne Coury, Rosalyn Sulyanto, Despina Sitara, Jing Wu, Nicholas J. Brady, Kelly Tsang, Kirsten S. Sigrist, Douglas M. Tollefsen, Li He, Daniel R. Storm, Antonios O. Aliprantis	33
19	MLK3 regulates bone development downstream of the faciogenital dysplasia protein FGD1 in mice 2011 ·Journal of Clinical Investigation ·Weiguo Zou, Matthew B. Greenblatt, Jae‐Hyuck Shim, Shashi Kant, Bo Zhai, Sutada Lotinun, Nicholas J. Brady, Dorothy Hu, Steven P. Gygi, (unknown), Roger J. Davis, Dallas C. Jones, Laurie H. Glimcher	51
20	The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid 2010 ·Nature Cell Biology ·Weiguo Zou, Xi Chen, Jae‐Hyuck Shim, Zhiwei Huang, Nicholas J. Brady, Dorothy Hu, Rebecca Drapp, Kirsten S. Sigrist, Laurie H. Glimcher, Dallas C. Jones	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact